` IMAB (I-Mab) vs S&P 500 Comparison - Alpha Spread

IMAB
vs
S&P 500

Over the past 12 months, IMAB has significantly outperformed S&P 500, delivering a return of +331% compared to the S&P 500's +16% growth.

Stocks Performance
IMAB vs S&P 500

Loading
IMAB
S&P 500
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
IMAB vs S&P 500

Loading
IMAB
S&P 500
Difference
www.alphaspread.com

Performance By Year
IMAB vs S&P 500

Loading
IMAB
S&P 500
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
I-Mab vs Peers

S&P 500
IMAB
ABBV
AMGN
GILD
VRTX
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

I-Mab
Glance View

Market Cap
335.6m USD
Industry
Biotechnology

I-Mab operates as a clinical stage biopharmaceutical company. The company is headquartered in Shanghai, Shanghai. The company went IPO on 2020-01-17.

IMAB Intrinsic Value
Not Available
Back to Top